News

Therapeutic target could prevent chronic gut inflammation from turning into cancer
Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of ...
The American Journal of Managed Care1d
Biosimilar Starjemza Gains FDA Approval as Ustekinumab Shows Significant Psoriasis-Itch Relief
Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...
gut.bmj4d
Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery
The aim of this study was to assess the evolution of the need for surgery in Crohn’s disease during the last 25 years. Patients and Methods: The medical charts of 2573 patients were reviewed ...
New once-a-month jab can eliminate distressing symptoms for patients with severe bowel diseases like Crohn’s and ulcerative colitis in only three months
Patients with severe bowel disease are set to benefit from a new drug that can eliminate their distressing symptoms in only ...
gut.bmj6d
Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease
bartsandthelondon.nhs.uk Background and aims: The intestinal microbiota play a pivotal role in the inflammation associated with Crohn’s disease through their interaction with the mucosal immune system ...